Bessler Robert 4

What Happened

• Robert Bessler, a director of LifeStance Health Group, Inc. (LFST), reported two open-market sales on June 26, 2026 totaling 894,337 shares disposed. The filing shows a weighted-average price of $10.13: 447,168 shares for $4,529,812 and 447,169 shares for $4,529,822, for aggregate proceeds of approximately $9,059,634. These were sales (not purchases), which are often routine liquidity events rather than bullish insider buying.

Key Details

• Transaction date: June 26, 2026; Form 4 filed June 30, 2026 (appears timely under the two-business-day SEC filing rule).
• Prices: weighted-average $10.13; sale price range reported as $10.00 to $10.295 (footnote F1).
• Shares sold: 447,168 and 447,169 (total 894,337); total proceeds ≈ $9,059,634.
• Shares owned after transaction: not specified in this filing.
• Notable footnotes:
  • F1: Price is a weighted average; seller can provide per-price breakdown on request.
  • F4/F2/F3: Shares are held of record by Alpine Glow Capital (Bessler is manager and sole member); Bessler disclaims beneficial ownership except for his pecuniary interest.
• Transaction code: S = Sale (open market or private sale).

Context

• Sales by directors can be for personal liquidity, tax, or portfolio reasons and do not necessarily indicate a change in company outlook. Because this filing reports outright sales (not option exercises or gifts), there is no immediate implication of additional share issuance or cashless exercise mechanics.